Ten challenges for clinical translation in psychiatric genetics.
- Authors
- Derks, Eske M; Thorp, Jackson G; Gerring, Zachary F
- Year
- 2022
- Journal
- Nature genetics
- PMID
- 36138228
- DOI
- 10.1038/s41588-022-01174-0
Genome-wide association studies have identified hundreds of robust genetic associations underlying psychiatric disorders and provided important biological insights into disease onset and progression. There is optimism that genetic findings will pave the way to precision psychiatry by facilitating the development of more effective treatments and the identification of groups of patients that these treatments should be targeted toward. However, there are several challenges that must be addressed before genetic findings can be translated into the clinic. In this Perspective, we highlight ten challenges for the field of psychiatric genetics, focused on the robust and generalizable detection of genetic risk factors, improved definition and assessment of psychopathology and achieving better clinical indicators. We discuss recent advancements in the field that will improve the explanatory and predictive power of genetic data and ultimately contribute to improving the management and treatment of patients with a psychiatric disorder.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | 2025 | 40360802 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genetic exploration of the relationship between liability to psychiatric disorders and acne vulgaris. | Mitchell BL et al. | — | 2026 | → |
| Software Application Profile: McBias: a user-friendly R package and RShiny application for modeling bias in observational studies. | Breidenbach A et al. | — | 2026 | → |
| Unravelling depression heterogeneity: Exploring the role of external risk factors in symptom network dynamics. | Yang T et al. | — | 2026 | → |
| Anxiety disorder, depression and coronary artery disease: associations and modification by genetic susceptibility. | Nakada S et al. | — | 2025 | → |
| Functional consequences of calmodulin variants identified among schizophrenia patients and controls. | Jensen HH et al. | — | 2025 | → |
| Genome-wide analyses identify 30 loci associated with obsessive-compulsive disorder. | Strom NI et al. | — | 2025 | → |
| Genomics-driven integrative analysis highlights immune-related plasma proteins for psychiatric disorders. | Gong W et al. | — | 2025 | → |
| Large language model powered knowledge graph construction for mental health exploration. | Gao S et al. | — | 2025 | → |
| Leveraging genomic and transcriptomic data of diverse ancestry to uncover mechanisms of psychiatric risk in the adult and developing brain. | Jajoo A et al. | — | 2025 | → |
| Leveraging pleiotropy for the improved treatment of psychiatric disorders. | Woodward DJ et al. | — | 2025 | → |
| Modeling psychopathology in high-dimensional vector space using the high-dimensional symptom space (HDSS) model can operationalize precision psychiatry in US adolescents. | Wild MG et al. | — | 2025 | → |
| NGS Approaches in Clinical Diagnostics: From Workflow to Disease-Specific Applications. | Brancato D et al. | — | 2025 | → |
| Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring. | Milosavljevic S et al. | — | 2025 | → |
| Passive Smartphone Sensors for Detecting Psychopathology. | Ringwald WR et al. | — | 2025 | → |
| Reevaluating the brain disease model of addiction. | Blithikioti C et al. | — | 2025 | → |
| Roles of genetic and environmental factors in psychiatric comorbidities among children with neurodevelopmental delays. | Li L et al. | — | 2025 | → |
| Surface receptor-targeted protein-based nanocarriers for drug delivery: advances in cancer therapy. | Theivendren P et al. | — | 2025 | → |
| Calmodulin variants in schizophrenia patients display gain-of-function or loss-of-function effects | Jensen HH et al. | — | 2024 | — |
| Human genetics and epigenetics of alcohol use disorder. | Zhou H et al. | — | 2024 | → |
| Incorporating genetic similarity of auxiliary samples into eGene identification under the transfer learning framework. | Zhang S et al. | — | 2024 | → |
| Stratifying early-onset emotional disorders: using genetics to assess persistence in young people of European and South Asian ancestry. | Dennison CA et al. | — | 2024 | → |
| The broken Alzheimer's disease genome. | Gouveia Roque C et al. | — | 2024 | → |
| The ethics of polygenic scores in psychiatry: minefield or opportunity for patient-centered psychiatry? | Wouters RHP et al. | — | 2024 | → |
| The genetic landscape of substance use disorders. | Gerring ZF et al. | — | 2024 | → |
| Identification of drug repurposing candidates for the treatment of anxiety: A genetic approach. | Woodward DJ et al. | — | 2023 | → |
| How can we obtain truly translational mouse models to improve clinical outcomes in schizophrenia? | Clapcote SJ | — | 2022 | → |